| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3865233 | The Journal of Urology | 2013 | 6 Pages |
Abstract
Solifenacin plus tamsulosin was well tolerated. There was a low incidence of urinary retention requiring catheterization. At week 12 solifenacin plus tamsulosin decreased daily micturitions and urgency episodes. Only urgency reached statistical significance vs placebo plus tamsulosin.
Keywords
patient perception of bladder conditionPPBCI-PSSPBOOABEOTTEAEAdrenergic alpha-antagonistsMuscarinic antagonistsBladder outlet obstructionTimesBOOOveractiveTAMTamsulosintreatment emergent adverse eventSolSolifenacinPVRadverse eventLower urinary tract symptomsUrinary bladderOveractive bladderLUTSInternational Prostate Symptom ScoreBenign prostatic hyperplasiaBPHend of treatmentpost-void residual PlaceboUPS
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Steven A. Kaplan, Kurt McCammon, Roger Fincher, Allam Fakhoury, Weizhong He,